A Cure for Cancer? How CAR-T Cell Therapy is Revolutionizing Oncology
CAR-T therapy has been hailed as a cure for cancer, but what really is this…
11/10/2021 - 10 minutes
CAR-T
Microbiome Medicines Could Power Up CAR-T Cell Therapies
The microbiome could pave new cancer immunotherapy inroads for European biotechs, bolstered by preclinical findings…
28/07/2021 - 5 minutes
Scotland’s Top Ten Biotech Companies to Watch Out For
Scotland has a thriving life sciences ecosystem with strengths in oncology, genetic engineering, and industrial…
30/06/2021 - 11 minutes
Navigating the Immunotherapy Maze
Today, the global immunotherapy drugs market is valued at €139B ($163B) and is estimated to…
11/11/2020 - 2 minutes
Do Natural Killer Cells Hold the Key to Treating Blood Cancers?
Novel immunotherapies, like T cell therapy, may have shown recent successes but they also come…
28/10/2020 - 7 minutes
From Big Pharma to Startup CEO: Lessons from Kymriah Developer Gaurav Shah
Novartis’ Kymriah, one of the first CAR T-cell therapies to be approved to treat blood…
28/09/2020 - 9 minutes
T-Cell Therapy Firm Wins Massive €93M Series A to Treat Solid Tumors
The Dutch startup Neogene Therapeutics has become the second T-cell therapy developer to raise a…
14/09/2020 - 3 minutes
How European Startups Have Advanced Cancer T-Cell Therapy in 2020
With the help of a huge €66M Series A round last week, the German startup…
11/08/2020 - 8 minutes
Sponsored
by Anemocyte
How Can We Tackle the Bottleneck in Plasmid Production for Gene Therapies?
The cell and gene therapy sector is booming. At the end of 2019, there were…
03/02/2020 - 5 minutes
T-Cell Discovery Could Herald Universal Cancer Immunotherapy
An international research team has found a new type of T-cell that could lead to…
21/01/2020 - 3 minutes
Adaptimmune to Take Off-The-Shelf CAR-T to Phase I with Astellas
The UK biotech Adaptimmune Therapeutics has inked a deal worth up to €806M with Japanese…
15/01/2020 - 2 minutes
BioNTech’s RNA-Boosted CAR T-Cell Therapy Shrinks Tumors in Mice
A CAR T-cell therapy amplified by RNA technology, developed by BioNTech, has shown preclinical potential…
06/01/2020 - 2 minutes
